Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Lipoic acid (also known as alpha-lipoic acid, or ALA) has been studied for its potential to support or treat nerve damage, particularly in the context of diabetic neuropathy. Multiple clinical trials, mostly conducted in Europe, have investigated the effects of oral and intravenous lipoic acid supplementation in patients with peripheral neuropathy. The most notable evidence comes from several randomized controlled trials and meta-analyses, which suggest that lipoic acid—especially when administered intravenously—can modestly improve neuropathic symptoms such as pain, burning, and numbness in patients with diabetes over short-term periods (3-5 weeks). The mechanism is thought to involve ALA’s antioxidant properties, its ability to improve nerve blood flow, and reduction of oxidative stress, which is implicated in nerve damage.

However, the quality of evidence varies. Some trials have methodological limitations, and the benefits observed are generally mild to moderate and seem more pronounced with intravenous rather than oral administration. Longer-term benefits and effects on nerve conduction have not been consistently demonstrated. Lipoic acid is used in clinical practice for neuropathy in some countries (notably Germany), but it is not universally recommended by major diabetes or neurology guidelines due to limited long-term data. In summary, there is moderate scientific evidence supporting the use of lipoic acid for diabetic neuropathy symptoms, but more research is needed to establish its efficacy and optimal use.

More about Lipoic Acid
More about Nerve Damage

Other ingredients used for Nerve Damage

Other health conditions supported by Lipoic Acid

Products containing Lipoic Acid